THE PITCH: TNeuroPharma received VC funding to commercialize a potential deterrent for Alzheimer's disease

Those with Alzheimer’s or those who care for someone with Alzheimer’s, face a daunting reality. There is no known cure for the disease, which is a type of progressive dementia that can inhibit an individual’s ability to carry out everyday activities.

One company in Albuquerque says it has the solution — with research to back up its claim. The startup, called TNeuroPharma, is commercializing two products meant to detect and deter Alzheimer’s.

Its platform is based on research conducted by TNeuroPharma’s…

Source: The Business Journal